Hospital Chain Operator HCA Healthcare Says Positive Q2 Earnings Reflect Strong Demand For Services, Issues Upbeat Annual Outlook
Hospital Chain Operator HCA Healthcare Says Positive Q2 Earnings Reflect Strong Demand For Services, Issues Upbeat Annual Outlook
On Tuesday, HCA Healthcare Inc. (NYSE:HCA) reported second-quarter revenues of $17.49 billion, up from $15.86 billion a year ago and beating the consensus of $17.05 billion.
HCA healthcare在周二发布了二季度财报，营业收入为174.9亿美元，高于去年同期的158.6亿美元，超过市场预期的170.5亿美元。
The hospital chain reported adjusted EPS of $5.50, up from $4.29 a year ago, beating the consensus of $5.36.
该医院连锁集团报告的调整后每股收益为5.50美元，高于去年同期的4.29美元，超过市场预期的5.36美元。
"The company's results for the second quarter were positive and reflected strong demand for our services," said Sam Hazen, Chief Executive Officer of HCA Healthcare.
HCA healthcare的首席执行官Sam Hazen表示：公司第二季度的业绩表现积极，反映了服务强劲的需求。
In the second quarter of 2024, same-facility admissions increased 5.8% year over year, while same-facility equivalent admissions increased 5.2%.
2024年第二季度，同单位设施收治人数同比增长5.8%，同单位等价收治人数同比增长5.2%。
Same-facility emergency room visits increased by 5.5%. Same-facility inpatient surgeries increased 2.6%, and same-facility outpatient surgeries declined 2.1%.
同一设施的急诊就诊人数增加了5.5%。手术室住院手术同比增长了2.6%，门诊手术同比下降了2.1%。
Same facility revenue per equivalent admission increased by 4.4%
同单位收入等价收治人数的营收增长了4.4%。
For the second quarter of 2024, adjusted EBITDA totaled $3.55 billion, compared to $3.06 billion a year ago.
2024年第二季度，调整后EBITDA总额为35.5亿美元，而去年同期为30.6亿美元。
Guidance: HCA Healthcare revised its fiscal year 2024 revenue guidance to $69.75 billion-$71.75 billion compared to prior guidance of $67.75 billion-$70.25 billion and the consensus of $69.79 billion.
指导方针：HCA Healthcare将其2024财年营收指导范围修正为697.5亿-717.5亿美元，而先前的指导为677.5亿-702.5亿美元，市场预期为697.9亿美元。
The company forecasts 2024 EPS guidance of $21.60-22.80, up from the prior guidance of $19.70-$21.20 and the consensus of $20.98.
该公司预测2024年每股收益指引为21.60-22.80美元，高于先前的指导范围19.70-21.20美元和市场预期20.98美元。
The company expects 2024 adjusted EBITDA of $12.85 billion-$13.55 billion versus the prior guidance of $13.75 billion-$14.25 billion.
该公司预计2024年调整后的EBITDA为128.5亿-135.5亿美元，而先前的指导范围为137.5亿-142.5亿美元。
Reuters reported that some analysts anticipate U.S. hospitals will benefit from an aging population, while others believe a shift also drives the increased demand for ambulatory care centers that don't require overnight stays.
路透社报道称，一些分析师预计美国医院将受益于人口老龄化，而其他人则认为，不需要夜盘交易的门诊诊所的增长也推动了对其增加需求。
Over the past year, demand for medical care has surged as Americans, particularly older adults, address non-urgent procedures delayed during the pandemic.
过去一年中，随着美国民众（特别是老年人）处理在大流行期间推迟的非紧急手术，对医疗保健的需求飙升。
According to a Reuters report citing Mizuho analyst, the largest for-profit hospital operator in the U.S. raised its forecast, meeting the high expectations for the quarter.
据彭博社报道，援引瑞银分析师的话称，美国最大的盈利性医院运营商之一HCA Healthcare提高了其预测，达到了季度的高预期。
The stock of peers Universal Health Services Inc (NYSE:UHS) and Community Health Systems Inc (NYSE:CYH) also trade higher.
同行的医疗公司Universal Health Services Inc（NYSE：UHS）和Community Health Systems Inc（NYSE：CYH）的股票也有所上涨。
Price Action: HCA Healthcare stock is up 4.81% at $341.33 at last check on Tuesday.
价格表现：HCA Healthcare股票于周二的最新交易中上涨了4.81%，报341.33美元。
- EXCLUSIVE: Adial Pharmaceuticals Moves Forward To Second Cohort In Pharmacokinetics Study of AD04 For Alcohol Use Disorder.
- Adial Pharmaceuticals独家报道：AD04用于酒精性障碍的药物代谢动力学研究进入第二队。
Photo via Company
照片来自公司